Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    0.00 (0.00%)
Bid:
0.00
Ask:
480.00
Spread: 480.00 (0.00%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Trading Statement

22 Apr 2013 07:00

RNS Number : 8378C
Creston PLC
22 April 2013
 



 

 

22 April 2013

Creston plc

 

Trading Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, provides an update on trading for the year ended 31 March 2013 ahead of its full year results for the period.

 

The Group expects to report full year revenue of £75 million (2012: £74.9 million) and to be in line with consensus Group Headline PBT. Following a strong cash conversion, and with operating cash flow ahead of Board expectations, the Group expects to be in a net cash position of over £10 million at the year end. This includes £6.5 million of the previously announced £7.2 million (including VAT) received as a reverse premium and contribution to the agreed dilapidations obligation for the Group's new London office.

 

Following a working partnership of over 20 years with Sanofi Pasteur, Cooney/Waters' contract with the client came to an end during the fourth quarter of the financial year just ended. Appropriate cost reductions were made in the fourth quarter to mitigate this revenue reduction, and it is expected that both the estimated future deferred consideration and the carrying value of goodwill for the Cooney/Waters Group will be reduced at the year end. On the back of the agency's excellent reputation for providing communications support, it has already begun to replace part of the Sanofi Pasteur revenue through developing a new client relationship.

 

The Group's most recent acquisition, DJM Digital Solutions Limited, is performing well and has been involved in several new business wins with other companies within the Health division.

 

There have been a number of other recent new business successes across the Group's divisions, most notably within Communications. All of the Group's agencies in its Communications division, as well as Red Door Communications from its Health division, have been appointed on a three year term to the UK Government Procurement Service's roster for marketing services (which includes digital marketing). The exact process to determine how work will be allocated to the agencies on the roster is still to be finalised. However, given the size of the budget and the fact that Creston is the most represented marketing communications group on this roster, it is expected to become a top five client for the Group during the three year appointment. In a second major win for the Communications division, it was announced on 19 April 2013 that Reckitt Benckiser UK is consolidating all of its digital activity across its portfolio of 19 brands into TMW.

 

The recovery within the Group's Insight division continued during the second half, and the Board expects it to report a stronger second half compared with the first half of the financial year.

 

Creston will announce its full year results for the year ended 31 March 2013 on Wednesday 12 June 2013.

 

-ends-

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson/Matthew Neal

 

 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including advertising, brand consultancy, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. Our insight companies give us a real edge, providing the analytic intelligence to enable us to truly understand, influence and inspire consumers and it's that insight-led intelligence that drives our creativity. www.creston.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUWWCUPWGQB
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.